| Gene symbol | HGF | Synonyms | DFNB39, F-TCF, HGFB, HPTA, SF | Type of gene | protein-coding |
| Chromosome | 7 | Map location | 7q21.11 | dbXrefs | |
| Description | hepatocyte growth factor | ||||
| GTO ID | GTC2314 |
| Trial ID | NCT04274049 |
| Disease | Glioblastoma |
| Altered gene | HGF |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | NL003 |
| Phase | Phase3 |
| Recruitment status | Recruiting |
| Title | A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of NL003 in Subject With Critical Limb Ischemia (Rutherford 5) |
| Year | 2020 |
| Country | China |
| Company sponsor | Beijing Northland Biotech. Co., Ltd. |
| Other ID(s) | NL003-CLI-III-2 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||
|
|||||||